Skip to main content
Erschienen in: Die Anaesthesiologie 6/2020

19.05.2020 | Lungenödem | CME

Ist es wirklich ein akutes Lungenversagen?

Aktuelle Definitionen, Pathophysiologie und Differentialdiagnosen

verfasst von: Prof. Dr. R. Dembinski

Erschienen in: Die Anaesthesiologie | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Obwohl die Berlin Definition des akuten Lungenversagens (ARDS) allgemein anerkannt ist, bleibt die Unterscheidung von anderen Erkrankungen mit schwerer Gasaustauschstörung in der klinischen Praxis oft schwierig. Insbesondere die Beurteilung der radiologischen Befunde und die Identifizierung des primär nichtkardiogenen Lungenödems bereiten Probleme. Beim ARDS finden sich typische inflammatorische Prozesse, in deren Mittelpunkt die Aktivierung neutrophiler Granulozyten steht. Antiinflammatorische Therapiestrategien waren nicht erfolgreich. Als evidenzbasierte Therapie sind nur die lungenprotektive Beatmung und die Lagerungstherapie anzusehen. Möglicherweise bietet die Phänotypisierung des ARDS entsprechend der Ätiologie oder des Krankheitsverlaufes die Möglichkeit der gezielten, individualisierten Therapie. Die Kontrolle verschiedener Biomarker zu Beurteilung und Therapie steht im Mittelpunkt des wissenschaftlichen Interesses. Die Ergebnisse entsprechender Studien bleiben abzuwarten.
Literatur
1.
Zurück zum Zitat Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319–323CrossRef Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319–323CrossRef
2.
Zurück zum Zitat Dembinski R, Mielck F (2018) ARDS—an update—part 2: therapy and outcome. Anasthesiol Intensivmed Notfallmed Schmerzther 53(2):112–125CrossRef Dembinski R, Mielck F (2018) ARDS—an update—part 2: therapy and outcome. Anasthesiol Intensivmed Notfallmed Schmerzther 53(2):112–125CrossRef
3.
Zurück zum Zitat Dembinski R, Mielck F (2018) ARDS—an update—part 1: epidemiology, pathophysiology and diagnosis. Anasthesiol Intensivmed Notfallmed Schmerzther 53(2):102–111CrossRef Dembinski R, Mielck F (2018) ARDS—an update—part 1: epidemiology, pathophysiology and diagnosis. Anasthesiol Intensivmed Notfallmed Schmerzther 53(2):102–111CrossRef
4.
Zurück zum Zitat Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533PubMed Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526–2533PubMed
5.
Zurück zum Zitat Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824CrossRef Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149(3 Pt 1):818–824CrossRef
6.
Zurück zum Zitat The ARDS Definition Task Force (2012) Acute respiratory distress syndrome: the Berlin definition. J Am Med Assoc 307(23):2526–2533 The ARDS Definition Task Force (2012) Acute respiratory distress syndrome: the Berlin definition. J Am Med Assoc 307(23):2526–2533
7.
Zurück zum Zitat Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788–800CrossRef Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, Gattinoni L, van Haren F, Larsson A, McAuley DF et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315(8):788–800CrossRef
8.
Zurück zum Zitat Sjoding MW, Hofer TP, Co I, Courey A, Cooke CR, Iwashyna TJ (2018) Interobserver reliability of the Berlin ARDS definition and strategies to improve the reliability of ARDS diagnosis. Chest 153(2):361–367CrossRef Sjoding MW, Hofer TP, Co I, Courey A, Cooke CR, Iwashyna TJ (2018) Interobserver reliability of the Berlin ARDS definition and strategies to improve the reliability of ARDS diagnosis. Chest 153(2):361–367CrossRef
9.
Zurück zum Zitat Sarmiento X, Guardiola JJ, Almirall J, Mesalles E, Mate JL, Soler M, Klamburg J (2011) Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage. Respir Med 105(8):1170–1175CrossRef Sarmiento X, Guardiola JJ, Almirall J, Mesalles E, Mate JL, Soler M, Klamburg J (2011) Discrepancy between clinical criteria for diagnosing acute respiratory distress syndrome secondary to community acquired pneumonia with autopsy findings of diffuse alveolar damage. Respir Med 105(8):1170–1175CrossRef
10.
Zurück zum Zitat Thille AW, Penuelas O, Lorente JA, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Panizo J, Esteban A, Frutos-Vivar F (2017) Predictors of diffuse alveolar damage in patients with acute respiratory distress syndrome: a retrospective analysis of clinical autopsies. Crit Care 21(1):254CrossRef Thille AW, Penuelas O, Lorente JA, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Panizo J, Esteban A, Frutos-Vivar F (2017) Predictors of diffuse alveolar damage in patients with acute respiratory distress syndrome: a retrospective analysis of clinical autopsies. Crit Care 21(1):254CrossRef
12.
Zurück zum Zitat Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, Bolton-Maggs P, Peters AL, Silliman CC, Kor DJ et al (2019) A consensus redefinition of transfusion-related acute lung injury. Transfusion 59(7):2465–2476CrossRef Vlaar APJ, Toy P, Fung M, Looney MR, Juffermans NP, Bux J, Bolton-Maggs P, Peters AL, Silliman CC, Kor DJ et al (2019) A consensus redefinition of transfusion-related acute lung injury. Transfusion 59(7):2465–2476CrossRef
14.
Zurück zum Zitat Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, Kathiresan S, Kenny EE, Lindgren CM, MacArthur DG et al (2020) A brief history of human disease genetics. Nature 577(7789):179–189CrossRef Claussnitzer M, Cho JH, Collins R, Cox NJ, Dermitzakis ET, Hurles ME, Kathiresan S, Kenny EE, Lindgren CM, MacArthur DG et al (2020) A brief history of human disease genetics. Nature 577(7789):179–189CrossRef
15.
Zurück zum Zitat Castillo RL, Carrasco Loza R, Romero-Dapueto C (2015) Pathophysiological approaches of acute respiratory distress syndrome: novel bases for study of lung injury. Open Respiratory Medicine J 9:83–91CrossRef Castillo RL, Carrasco Loza R, Romero-Dapueto C (2015) Pathophysiological approaches of acute respiratory distress syndrome: novel bases for study of lung injury. Open Respiratory Medicine J 9:83–91CrossRef
16.
Zurück zum Zitat Millar FR, Summers C, Griffiths MJ, Toshner MR, Proudfoot AG (2016) The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities. Thorax 71(5):462–473CrossRef Millar FR, Summers C, Griffiths MJ, Toshner MR, Proudfoot AG (2016) The pulmonary endothelium in acute respiratory distress syndrome: insights and therapeutic opportunities. Thorax 71(5):462–473CrossRef
17.
Zurück zum Zitat Aikawa N, Kawasaki Y (2014) Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome. Ther Clin Risk Manag 10:621–629PubMedPubMedCentral Aikawa N, Kawasaki Y (2014) Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome. Ther Clin Risk Manag 10:621–629PubMedPubMedCentral
18.
Zurück zum Zitat Rice WG, Weiss SJ (1990) Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249(4965):178–181CrossRef Rice WG, Weiss SJ (1990) Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249(4965):178–181CrossRef
19.
Zurück zum Zitat Wang T, Zhu Z, Liu Z, Yi L, Yang Z, Bian W, Chen W, Wang S, Li G, Li A et al (2017) Plasma neutrophil elastase and elafin as prognostic biomarker for acute respiratory distress syndrome: a multicenter survival and longitudinal prospective observation study. Shock 48(2):168–174CrossRef Wang T, Zhu Z, Liu Z, Yi L, Yang Z, Bian W, Chen W, Wang S, Li G, Li A et al (2017) Plasma neutrophil elastase and elafin as prognostic biomarker for acute respiratory distress syndrome: a multicenter survival and longitudinal prospective observation study. Shock 48(2):168–174CrossRef
20.
Zurück zum Zitat de Beer FM, Begieneman MPV, Roelofs J, Horn J, Niessen HWM, Schultz MJ, Lagrand WK (2019) Pulmonary complement depositions in autopsy of critically ill patients have no relation with ARDS. Intensive Care Med Exp 7(1):35CrossRef de Beer FM, Begieneman MPV, Roelofs J, Horn J, Niessen HWM, Schultz MJ, Lagrand WK (2019) Pulmonary complement depositions in autopsy of critically ill patients have no relation with ARDS. Intensive Care Med Exp 7(1):35CrossRef
22.
Zurück zum Zitat Blondonnet R, Constantin JM, Sapin V, Jabaudon M (2016) A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016:3501373CrossRef Blondonnet R, Constantin JM, Sapin V, Jabaudon M (2016) A pathophysiologic approach to biomarkers in acute respiratory distress syndrome. Dis Markers 2016:3501373CrossRef
23.
Zurück zum Zitat Zochios V, Parhar K, Tunnicliffe W, Roscoe A, Gao F (2017) The right ventricle in ARDS. Chest 152(1):181–193CrossRef Zochios V, Parhar K, Tunnicliffe W, Roscoe A, Gao F (2017) The right ventricle in ARDS. Chest 152(1):181–193CrossRef
24.
Zurück zum Zitat Mekontso Dessap A, Boissier F, Charron C, Begot E, Repesse X, Legras A, Brun-Buisson C, Vignon P, Vieillard-Baron A (2016) Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med 42(5):862–870CrossRef Mekontso Dessap A, Boissier F, Charron C, Begot E, Repesse X, Legras A, Brun-Buisson C, Vignon P, Vieillard-Baron A (2016) Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med 42(5):862–870CrossRef
25.
Zurück zum Zitat Tagami T, Ong MEH (2018) Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? Curr Opin Crit Care 24(3):209–215CrossRef Tagami T, Ong MEH (2018) Extravascular lung water measurements in acute respiratory distress syndrome: why, how, and when? Curr Opin Crit Care 24(3):209–215CrossRef
27.
Zurück zum Zitat Thille AW, Richard JC, Maggiore SM, Ranieri VM, Brochard L (2007) Alveolar recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome: comparison using pressure-volume curve or static compliance. Anesthesiology 106(2):212–217CrossRef Thille AW, Richard JC, Maggiore SM, Ranieri VM, Brochard L (2007) Alveolar recruitment in pulmonary and extrapulmonary acute respiratory distress syndrome: comparison using pressure-volume curve or static compliance. Anesthesiology 106(2):212–217CrossRef
28.
Zurück zum Zitat Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786CrossRef Gattinoni L, Caironi P, Cressoni M, Chiumello D, Ranieri VM, Quintel M, Russo S, Patroniti N, Cornejo R, Bugedo G (2006) Lung recruitment in patients with the acute respiratory distress syndrome. N Engl J Med 354(17):1775–1786CrossRef
29.
Zurück zum Zitat Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63(12):1083–1089CrossRef Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63(12):1083–1089CrossRef
30.
Zurück zum Zitat Ware LB, Calfee CS (2016) Biomarkers of ARDS: what’s new? Intensive Care Med 42(5):797–799CrossRef Ware LB, Calfee CS (2016) Biomarkers of ARDS: what’s new? Intensive Care Med 42(5):797–799CrossRef
31.
Zurück zum Zitat Mekontso Dessap A, Ware LB, Bagshaw SM (2016) How could biomarkers of ARDS and AKI drive clinical strategies? Intensive Care Med 42(5):800–802CrossRef Mekontso Dessap A, Ware LB, Bagshaw SM (2016) How could biomarkers of ARDS and AKI drive clinical strategies? Intensive Care Med 42(5):800–802CrossRef
32.
Zurück zum Zitat Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB (2014) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 42(3):691–700CrossRef Terpstra ML, Aman J, van Nieuw Amerongen GP, Groeneveld AB (2014) Plasma biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 42(3):691–700CrossRef
33.
Zurück zum Zitat Jabaudon M, Berthelin P, Pranal T, Roszyk L, Godet T, Faure JS, Chabanne R, Eisenmann N, Lautrette A, Belville C et al (2018) Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study. Sci Rep 8(1):2603CrossRef Jabaudon M, Berthelin P, Pranal T, Roszyk L, Godet T, Faure JS, Chabanne R, Eisenmann N, Lautrette A, Belville C et al (2018) Receptor for advanced glycation end-products and ARDS prediction: a multicentre observational study. Sci Rep 8(1):2603CrossRef
34.
Zurück zum Zitat Xu Z, Wu GM, Li Q, Ji FY, Shi Z, Guo H, Yin JB, Zhou J, Gong L, Mei CX et al (2018) Predictive value of combined LIPS and ANG‑2 level in critically ill patients with ARDS risk factors. Mediators Inflamm 2018:1739615PubMedPubMedCentral Xu Z, Wu GM, Li Q, Ji FY, Shi Z, Guo H, Yin JB, Zhou J, Gong L, Mei CX et al (2018) Predictive value of combined LIPS and ANG‑2 level in critically ill patients with ARDS risk factors. Mediators Inflamm 2018:1739615PubMedPubMedCentral
35.
Zurück zum Zitat Ware LB, Zhao Z, Koyama T, Brown RM, Semler MW, Janz DR, May AK, Fremont RD, Matthay MA, Cohen MJ et al (2017) Derivation and validation of a two-biomarker panel for diagnosis of ARDS in patients with severe traumatic injuries. Trauma Surg Acute Care Open 2(1):e121CrossRef Ware LB, Zhao Z, Koyama T, Brown RM, Semler MW, Janz DR, May AK, Fremont RD, Matthay MA, Cohen MJ et al (2017) Derivation and validation of a two-biomarker panel for diagnosis of ARDS in patients with severe traumatic injuries. Trauma Surg Acute Care Open 2(1):e121CrossRef
36.
Zurück zum Zitat Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296CrossRef Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA (2010) Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 137(2):288–296CrossRef
37.
Zurück zum Zitat Reilly JP, Calfee CS, Christie JD (2019) Acute respiratory distress syndrome phenotypes. Semin Respir Crit Care Med 40(1):19–30CrossRef Reilly JP, Calfee CS, Christie JD (2019) Acute respiratory distress syndrome phenotypes. Semin Respir Crit Care Med 40(1):19–30CrossRef
38.
Zurück zum Zitat Cherian SV, Kumar A, Akasapu K, Ashton RW, Aparnath M, Malhotra A (2018) Salvage therapies for refractory hypoxemia in ARDS. Respir Med 141:150–158CrossRef Cherian SV, Kumar A, Akasapu K, Ashton RW, Aparnath M, Malhotra A (2018) Salvage therapies for refractory hypoxemia in ARDS. Respir Med 141:150–158CrossRef
39.
Zurück zum Zitat Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI, Gries B, Rafiq A, Faulhammer P, Goldenberg A et al (2009) Intermedin/adrenomedullin‑2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 297(5):L837–845CrossRef Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI, Gries B, Rafiq A, Faulhammer P, Goldenberg A et al (2009) Intermedin/adrenomedullin‑2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 297(5):L837–845CrossRef
40.
Zurück zum Zitat McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, Johnston P, Hopkins PA, Johnston AJ, McDowell C et al (2014) Simvastatin in the acute respiratory distress syndrome. N Engl J Med 371(18):1695–1703CrossRef McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, Johnston P, Hopkins PA, Johnston AJ, McDowell C et al (2014) Simvastatin in the acute respiratory distress syndrome. N Engl J Med 371(18):1695–1703CrossRef
41.
Zurück zum Zitat Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O’Kane CM, McAuley DF (2018) Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 6(9):691–698CrossRef Calfee CS, Delucchi KL, Sinha P, Matthay MA, Hackett J, Shankar-Hari M, McDowell C, Laffey JG, O’Kane CM, McAuley DF (2018) Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial. Lancet Respir Med 6(9):691–698CrossRef
Metadaten
Titel
Ist es wirklich ein akutes Lungenversagen?
Aktuelle Definitionen, Pathophysiologie und Differentialdiagnosen
verfasst von
Prof. Dr. R. Dembinski
Publikationsdatum
19.05.2020
Verlag
Springer Medizin
Erschienen in
Die Anaesthesiologie / Ausgabe 6/2020
Print ISSN: 2731-6858
Elektronische ISSN: 2731-6866
DOI
https://doi.org/10.1007/s00101-020-00789-4

Weitere Artikel der Ausgabe 6/2020

Die Anaesthesiologie 6/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.